Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis

NCT01647451 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01647451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01647451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
August 31, 2013
Enrollment
62 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, rheumatoid arthritis